Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
The company sees the business reaching $100mn
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Subscribe To Our Newsletter & Stay Updated
